CoChat

Assessing anaphylactic risk? Consider mast cell clonality

Open access
Metcalfe, Dean D., Schwartz, Lawrence B. · 2009 · Journal of Allergy and Clinical Immunology
Cited by 52

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

The ability to predict risk for severe anaphylaxis is an important goal for physicians. Bonadonna et al advance this effort with data from a 3-year prospective study that analyzed 44 patients with a serum baseline total tryptase (sBT) level >11.4 ng/mL who were culled from 379 patients with a previous systemic immediate hypersensitivity reaction to a Hymenoptera sting. Their data indicate that the majority of such patients have an underlying clonal mast cell disorder, either systemic mastocytosis or monoclonal mast cell activation syndrome, by assessing the bone marrow for mast cell granulomas, spindle-shaped mast cells, and mast cells expressing surface CD2 or CD25; and the serum for an elevated sBT level. This is the most comprehensive study to date of the relationships among Hymenoptera sting–induced anaphylaxis, sBT levels, and mast cell clonality. The article raises important issues relating to sBT levels and activating mutations in c-kit, which codes for KIT, the receptor for stem cell factor, (which appear to result in a hyperresponsive mast cell phenotype) as biomarkers for anaphylactic risk. Serum baseline total tryptase levels elevated in the setting of a hypotensive or systemic immediate hypersensitivity event—that is, anaphylaxis—have been used as evidence of mast cell degranulation. Persistent elevation in sBT >20 ng/mL has been set as a minor diagnostic criterion for the diagnosis of mastocytosis. Importantly, in this study by Bonadonna et al, a sBT level of >11.4 ng/mL not only identified patients likely to have a clonal mast cell disorder but also those at risk for systemic anaphylaxis. In fact, an odds ratio of 6.2 (95% CI, 3.1-12.4) can be calculated for having had a stage IV anaphylactic reaction if the sBT level was >11.4 ng/mL among the patient group with a systemic reaction to a Hymenoptera sting. A heightened risk for more severe anaphylactic reactions to Hymenoptera stings in those with an elevated sBT has been noted previously. An analogous odds ratio calculation for risk of mast cell clonality in subjects with

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2009.02.003

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 52

Metadata

Authors
Metcalfe, D. D., & Schwartz, L. B.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2009-03
Volume
123
Issue
3
Pages
687-688
ISSN
0091-6749 (ISSN-L)
OpenAlex
W2095705376
Cited by
52
References
8
FWCI
2.93
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessing anaphylactic risk? Consider mast cell clonality. https://app.cochat.ai/papers/10.1016/j.jaci.2009.02.003
The paper
Metcalfe, D. D., & Schwartz, L. B. (2009). Assessing anaphylactic risk? Consider mast cell clonality. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2009.02.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.